Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

(Cost)-Effectiveness of Optical Coherence Tomography Versus Regular Punch Biopsy in the Diagnosis and Subtyping of Basal Cell Carcinoma: a Multi Center Randomized Non-inferiority Trial

NCT03848078 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT03848078
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03848078 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
(Cost)-Effectiveness of Optical Coherence Tomography Versus Regular Punch Biopsy in the Diagnosis and Subtyping of Basal Cell Carcinoma: a Multi Center Randomized Non-inferiority Trial
Lead sponsor
Maastricht University Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
February 26, 2019
Completion date
October 31, 2021
Enrollment
598 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

basal cell carcinoma, optical coherence tomography